Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigen
Open Access
- 14 July 2024
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 136-137, 108938
Abstract
No abstract availableKeywords
Funding Information
- University of Missouri
This publication has 34 references indexed in Scilit:
- Theranostic PSMA ligands with optimized backbones for intraoperative multimodal imaging and photodynamic therapy of prostate cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- PET Imaging of VLA-4 in a New BRAFV600E Mouse Model of MelanomaMolecular Imaging and Biology, 2021
- 99mTechnetium-based Prostate-specific Membrane Antigen–radioguided Surgery in Recurrent Prostate CancerEuropean Urology, 2019
- Targeting prostate cancer: Prostate‐specific membrane antigen based diagnosis and therapyMedicinal Research Reviews, 2018
- „PSMA-radioguided surgery“ beim lokalisierten ProstatakarzinomrezidivDer Urologe, 2017
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative IntentEuropean Urology, 2017
- „PSMA-radioguided surgery“ beim lokal begrenzten ProstatakarzinomrezidivDer Urologe, 2016
- Targeted Radionuclide and Fluorescence Dual-modality Imaging of Cancer: Preclinical Advances and Clinical TranslationMolecular Imaging and Biology, 2014
- Positive Surgical Margins After Radical Prostatectomy: A Systematic Review and Contemporary UpdateEuropean Urology, 2014
- Sequential SPECT and Optical Imaging of Experimental Models of Prostate Cancer with a Dual Modality Inhibitor of the Prostate‐Specific Membrane AntigenAngewandte Chemie International Edition, 2011